Sleep Apnea Diagnostic Systems Market Report 2026

The sleep apnea diagnostic systems market size has grown strongly in recent years. It will grow from $6.78 billion in 2025 to $7.32 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited diagnostic awareness, reliance on in-lab sleep studies, increasing prevalence of obstructive sleep apnea, adoption of traditional polysomnography, rising obesity rates.

The sleep apnea diagnostic systems market size is expected to see strong growth in the next few years. It will grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growth in home sleep apnea testing, development of AI-based diagnostic algorithms, integration with telehealth platforms, expansion of wearable sleep devices, increasing insurance coverage for sleep diagnostics. Major trends in the forecast period include development of portable sleep monitoring devices, increasing adoption of home-based polysomnography, growth in AI-assisted sleep analysis, integration with wearable health devices, rising demand for patient-centric diagnostic solutions.

The increasing aging population is expected to drive the growth of the sleep apnea diagnostic systems market in the coming years. An aging population refers to a demographic trend where the share of elderly individuals in the total population rises due to longer life expectancy and lower birth rates. This trend is fueled by improvements in healthcare and living conditions, allowing more people to reach older ages. Sleep apnea diagnostic systems benefit the aging population by detecting and monitoring sleep apnea, a condition more prevalent in older adults, thereby improving sleep quality, reducing cardiovascular risks, and enhancing overall health and daily functioning. For example, in July 2024, the UK Parliament's House of Commons Library reported that in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This figure is projected to increase to 22.1 million by 2072, accounting for 27% of the population. Consequently, the growing aging population is driving the expansion of the sleep apnea diagnostic systems market.

Key players in the sleep apnea diagnostic systems market are emphasizing the development of innovative technologies, such as pneumatic sensors, to improve the accuracy, efficiency, and comfort of sleep apnea detection and monitoring, thereby enhancing patient outcomes and expanding market reach. Pneumatic sensors measure airflow and pressure changes in the respiratory system to identify irregular breathing patterns, supporting sleep apnea diagnosis. For instance, in September 2024, Withings Inc., a France-based consumer electronics company, received FDA approval for the Sleep Rx Mat, a contactless sleep apnea diagnostic device designed to track sleep patterns, detect apnea events, and provide actionable insights to improve sleep health. This device incorporates a pneumatic sensor to monitor respiratory rate, body movement, and continuous heart rate. Designed as a discreet mat, it requires only a one-time setup and fits under any mattress, eliminating the need for masks or bulky equipment. Once in place, it provides comprehensive analyses of sleep patterns, breathing, and cardiovascular activity throughout the night.

In May 2023, DynaFlex, a US-based orthodontic supplies and manufacturing company, acquired WholeYou/Respire Medical for an undisclosed amount. This acquisition enables DynaFlex to expand its obstructive sleep apnea (OSA) product range, strengthen its market position, and ensure continued delivery of high-quality services to meet both current and future customer needs. WholeYou/Respire Medical is a US-based medical equipment manufacturer specializing in developing solutions for obstructive sleep apnea.

Major companies operating in the sleep apnea diagnostic systems market are Koninklijke Philips N.V., GE Healthcare Technologies Inc., ResMed Inc., Nihon Kohden Corporation, Fisher And Paykel Healthcare, DeVilbiss Healthcare LLC, Natus Medical Incorporated, Itamar Medical Ltd., BMC Medical Co. Ltd., Compumedics Ltd., Advanced Brain Monitoring Inc., Cleveland Medical Devices Inc., NeuroVirtual, FusionSleep, Lowenstein Medical, Braebon Medical Corporation, Acurable, SOMNOmedics GmbH, Nox Medical, Drive DeVilbiss Healthcare, Masimo Corporation, Nonin Medical.

North America was the largest region in the sleep apnea diagnostic systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleep apnea diagnostic systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep apnea diagnostic systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have raised costs in the sleep apnea diagnostic systems market by increasing prices for imported polysomnography devices, sensors, wearable monitors, and diagnostic software platforms. Hospitals, sleep centers, and home-care providers in Asia-Pacific and emerging markets are most affected due to international sourcing of diagnostic hardware. These higher costs can delay equipment upgrades and expansion of sleep testing services. However, tariffs are driving local assembly and software-based diagnostic solutions, strengthening regional supply chains in the sleep apnea diagnostic systems market.

The sleep apnea diagnostic systems market research report is one of a series of new reports that provides sleep apnea diagnostic systems market statistics, including sleep apnea diagnostic systems industry global market size, regional shares, competitors with a sleep apnea diagnostic systems market share, detailed sleep apnea diagnostic systems market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea diagnostic systems industry. This sleep apnea diagnostic systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sleep apnea diagnostic systems are medical technologies and devices designed to detect, monitor, and evaluate sleep-related breathing disorders, particularly sleep apnea. They are used to assess physiological parameters such as airflow, oxygen saturation, heart rate, and brain activity during sleep to identify disruptions, enabling accurate diagnosis and effective management of the condition.

The primary products in sleep apnea diagnostic systems include polysomnography devices, nasal flow sensors, peripheral capillary oxygen saturation monitors, and actigraphy monitoring devices. Polysomnography devices are comprehensive systems that monitor and record various physiological parameters. These devices are crucial for diagnosing sleep disorders like sleep apnea, as they provide detailed data on sleep stages and disturbances. The technologies involved include non-invasive technology, invasive technology, wearable technology, and diagnostic software, and they are used by multiple end users, including in-home care settings, hospitals, and sleep centers and clinics.

The sleep apnea diagnostic systems market consists of revenues earned by entities by providing services such as in-laboratory polysomnography (PSG) testing, home sleep testing (HST), and telemedicine and remote consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The sleep apnea diagnostic systems market includes sales of snore sensors, pulse oximeters, airflow monitors, home sleep testing (HST) devices, and electroencephalogram (EEG) sensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.